BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.692
-0.498 (-41.82%)
At close: Dec 20, 2024, 4:00 PM
0.730
+0.038 (5.45%)
After-hours: Dec 20, 2024, 7:45 PM EST
BioAtla Market Cap
BioAtla has a market cap or net worth of $33.47 million as of December 20, 2024. Its market cap has decreased by -54.95% in one year.
Market Cap
33.47M
Enterprise Value
-21.80M
1-Year Change
-54.95%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $33.47M, a decrease of -94.21%. That is a compound annual growth rate of -50.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 33.47M | -71.62% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pheton Holdings | 58.57M |
| WORK Medical Technology Group LTD | 58.37M |
| Outset Medical | 58.32M |
| DBV Technologies | 58.11M |
| Scilex Holding Company | 58.00M |
| Modular Medical | 57.40M |
| Atara Biotherapeutics | 57.19M |
| Aadi Bioscience | 57.18M |